A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.

Bioimpacts · 2018 · PMC6128972 · PMID 30211081

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

close to significanceP = 0.056so close (0.05 < p ≤ 0.1)

Importantly, among the different vaccine formulations tested, this latter condition was the one characterized by the longest median animal survival with an improvement close to significance compared to either 4-DCs pulsed with the same antigen source ( P = 0.056) or α-DCs pulsed with ID8-ova-HOCl ( P = 0.055).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.